Skip to main content
Funded Studies

Supplement: Investigation of PINK1-dependent Phosphorylation of Rab GTPases

Promising Outcomes of Original Grant:
We were trying to understand how the PINK1 gene targets a set of proteins known as Rab GTPases through protein modification known as phosphorylation. The highlight of our studies was the discovery that boosting PINK1-induced phosphorylation of Rab8A may have therapeutic potential by dampening another Parkinson’s gene known as LRRK2, which also targets Rab GTPases. This involved the successful generation of the modified/phosphorylated Rab protein and the development of a powerful antibody tool to track Rab phosphorylation by PINK1 in cells.

Objectives for Supplemental Investigation:
Our studies have highlighted that another enzyme directly targets the Rab GTPases once PINK1 is activated. We will perform a genetic screen to uncover the identity of this enzyme and test its ability to directly target Rab GTPases and determine how its function is controlled by PINK1.

Importance of This Research for the Development of a New PD Therapy:
Our studies so far suggest that targeting this unknown enzyme is likely to offer a potential therapeutic strategy to dampen the activity of the LRRK2 protein in patients with LRRK2 hyper-activating mutations.


  • Miratul Muqit, MD, PhD

    Dundee United Kingdom

Discover More Grants

Search by Related Keywords

Within the Same Program

Within the Same Funding Year

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.